Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.

Wenzhong Li1, Nan Ma, Lee-Lee Ong

  • 1Department of Cardiac Surgery, University Rostock, Schillingallee 69, Rostock, Germany.

Stem Cells (Dayton, Ohio)
|May 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tyrosinase Cross-Linked PEG Hydrogels with DAT and DATT as Artificial Substrates: Design, Structure, and Functions.

Biomacromolecules·2026
Same author

Substrates mimicking the blastocyst geometry revert pluripotent stem cell to naivety.

Nature materials·2024
Same author

Recent advances in mesenchymal stem cell therapy for myocardial infarction.

Clinical hemorheology and microcirculation·2024
Same author

Multivariate Analysis of Cellular Uptake Characteristics for a (Co)polymer Particle Library.

ACS biomaterials science & engineering·2024
Same author

Cardiomyocyte precursors generated by direct reprogramming and molecular beacon selection attenuate ventricular remodeling after experimental myocardial infarction.

Stem cell research & therapy·2023
Same author

Sarcomeric network analysis of ex vivo cultivated human atrial appendage tissue using super-resolution microscopy.

Scientific reports·2023

Genetically modifying mesenchymal stem cells (MSCs) with the Bcl-2 gene enhances their survival and function after heart attack. This approach improves cell engraftment, reduces infarct size, and promotes recovery in myocardial infarction models.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Gene Therapy

Background:

  • Mesenchymal stem cells (MSCs) show therapeutic potential for post-heart attack left ventricular dysfunction.
  • Limited MSC survival in the heart restricts their regenerative capacity.
  • Genetic modification offers a strategy to enhance MSC viability and efficacy.

Purpose of the Study:

  • To genetically engineer bone marrow-derived MSCs with the antiapoptotic Bcl-2 gene.
  • To evaluate the impact of Bcl-2 gene modification on MSC survival, engraftment, and function in a myocardial infarction model.
  • To assess the therapeutic potential of Bcl-2-modified MSCs for cardiac repair.

Main Methods:

  • MSCs were genetically modified to overexpress the Bcl-2 gene.

Related Experiment Videos

  • In vitro studies assessed antiapoptotic and paracrine effects under hypoxia.
  • In vivo studies involved intracardiac injection of Bcl-2-MSCs in a rat myocardial infarction model.
  • Cell survival, capillary density, infarct size, and left ventricular function were evaluated.

    • Main Results:

    • Bcl-2 overexpression significantly reduced MSC apoptosis by 32% and increased vascular endothelial growth factor secretion by over 60% under hypoxic conditions.
    • Transplantation with Bcl-2-MSCs led to significantly improved cell survival at 4 days, 3 weeks, and 6 weeks compared to control groups.
    • Bcl-2-MSC treatment resulted in a 15% increase in capillary density, a 17% reduction in infarct size, and remarkable functional recovery.

    Conclusions:

    • Transplantation of antiapoptotic gene-modified MSCs significantly enhances cell survival and cardiac function after myocardial infarction.
    • Bcl-2 gene modification represents a promising strategy to improve the therapeutic efficacy of MSCs for treating heart damage.
    • This approach holds potential for mediating substantial functional recovery in patients with acute myocardial infarction.